Suppr超能文献

从印度香料中提取马汉宁富集部分用于癌症管理的临床前开发:功效、温度/ pH 稳定性、药代动力学、急性和慢性毒性(14-180 天)研究。

Preclinical Development of Mahanine-Enriched Fraction from Indian Spice for the Management of Cancer: Efficacy, Temperature/pH stability, Pharmacokinetics, Acute and Chronic Toxicity (14-180 Days) Studies.

机构信息

Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology, 4, Raja S.C. Mallick Road, Kolkata 700032, India.

出版信息

Biomed Res Int. 2020 Aug 10;2020:4638132. doi: 10.1155/2020/4638132. eCollection 2020.

Abstract

is well documented in the Indian ancient medical text "Charaka Samhita." The carbazole alkaloid "mahanine" from this plant exhibited anticancer activity against several cancers. Here, we have taken a comprehensive study to standardize the method for the preparation of a mahanine-enriched fraction (MEF) with the highest yield and defined markers. Our optimized method produced MEF having the highest amount of mahanine, a major marker, with excellent antiproliferative activity against ovarian and breast cancer cells as evidenced by decreased cell viability by MTT assay. Moreover, it exhibited condensed and fragmented nuclei by DAPI staining and increased annexin V-/PI-stained cells after MEF treatment, indicating apoptosis. It also exhibited good efficacy in ovarian and breast cancer syngeneic mice models, with an ED50 of 300 mg/kg body weight (BW). MEF is stable up to 40°C for ≥3 months. Its biological activity remains unchanged at a wide range of pH (1-10) for up to ~3 hours, indicating a safe oral route of administration. Additionally, the comparative pharmacokinetics of MEF and mahanine in rats showed a 31% higher bioavailability of mahanine in MEF-fed rats compared to rats fed with mahanine alone. Furthermore, mice fed with MEF at 5000 mg/kg BW single dose, 300-1500 mg/kg BW/day for 14 days, and 300 mg/kg BW/day for 28, 90, and 180 days for subacute, subchronic, chronic studies, respectively, did not show any significant clinical signs of toxicity, behavioral changes, mortality, organ weights, serum biochemistry, and hematological parameters indicating no/minimum toxicity for up to 180 days. To the best of our knowledge, this is the first report showing the pH/temperature stability and chronic toxicity studies of MEF along with efficacy against breast cancer. Taken together, our study will enhance the commercial value of this highly potential medicinal plant and will be helpful as a reference material for its clinical development.

摘要

在印度古代医学文本《查拉卡桑希塔》中对此有详细记载。这种植物中的咔唑生物碱“马汉宁”对多种癌症具有抗癌活性。在这里,我们进行了一项全面的研究,以标准化方法制备产率最高且具有明确标记物的马汉宁富集部分(MEF)。我们优化的方法产生了 MEF,其中含有最高量的马汉宁,这是一种主要标记物,对卵巢癌和乳腺癌细胞具有出色的抗增殖活性,这一点通过 MTT 测定法证实了细胞活力降低。此外,它通过 DAPI 染色显示出浓缩和碎片化的核,并在 MEF 处理后增加了 Annexin V-/PI-染色的细胞,表明发生了细胞凋亡。它在卵巢癌和乳腺癌同基因小鼠模型中也表现出良好的疗效,ED50 为 300mg/kg 体重(BW)。MEF 在 40°C 下稳定≥3 个月。其生物活性在 pH 值为 1-10 的宽范围内保持不变,最多可达约 3 小时,表明口服给药途径安全。此外,MEF 和马汉宁在大鼠中的比较药代动力学研究表明,与单独给予马汉宁的大鼠相比,给予 MEF 的大鼠中马汉宁的生物利用度提高了 31%。此外,分别以 5000mg/kg BW 单次剂量、14 天 300-1500mg/kg BW/天以及 28、90 和 180 天 300mg/kg BW/天的剂量给予 MEF 的小鼠,在亚急性、亚慢性和慢性研究中,均未显示任何毒性的临床体征、行为变化、死亡率、器官重量、血清生化和血液学参数的变化,表明在 180 天内无/最小毒性。据我们所知,这是首次报道 MEF 的 pH/温度稳定性和慢性毒性研究以及对乳腺癌的疗效。综上所述,我们的研究将提高这种极具潜力的药用植物的商业价值,并将有助于为其临床开发提供参考材料。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b731/7439207/228fa0ab892a/BMRI2020-4638132.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验